Drug Trial Radar · NCT07124000
DESTINY-PANTUMOUR04
Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Sep 18, 2025
Primary completion
Mar 30, 2028
Study completion Mar 30, 2028
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Aug 15, 2025
Design
- Study type
- Observational
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 130 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the effectiveness of T-DXd in patients with HER2-positive (IHC 3+) locally advanced, unresectable, or metastatic solid tumors who have received prior systemic treatment for metastatic or advanced disease and have no satisfactory alternative treatment options in a real-world setting in the US
Conditions
- Adenocarcinoma (NOS)
- Anal Cancer
- Bladder Cancer
- Cervical Cancer
- Endometrial Cancer
- Esophageal Cancer
- Gall Bladder Cancer
- Gastrointestinal Stromal Tumour
- Head and Neck Cancer
- Liver Cancer
- Melanoma
- Mouth Cancer
- Nasopharangeal Cancer
- Neuroendocrine, Gastrointestinal Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Prostate Cancer
- Renal Cell Carcinoma
- Salivary Gland Cancer
- Sarcoma
- Small Cell Lung Cancer
- Testicular Cancer
- Throat Cancer
- Thyroid Cancer
- Urethral Cancer
- Vaginal Cancer
- Vulvar Cancer
Interventions
Trastuzumab deruxtecanDrug
Trastuzumab deruxtecan monotherapy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Real world response rate (rwRR)Time frame: Through study completion, up to 2.5 years after enrolment
- Real world duration of response (rwDoR)Time frame: Through study completion, up to 2.5 years after enrolment
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Research Site
Birmingham, Alabama · Recruiting
Research Site
Bullhead City, Arizona · Recruiting
Research Site
Casa Grande, Arizona · Recruiting
Research Site
San Diego, California · Recruiting
Research Site
Boulder, Colorado · Recruiting
Research Site
Coral Springs, Florida · Recruiting
Research Site
St. Petersburg, Florida · Recruiting
Research Site
West Palm Beach, Florida · Recruiting
Research Site
Decatur, Illinois · Recruiting
Research Site
Topeka, Kansas · Recruiting
Research Site
Farmington, New Mexico · Recruiting
Research Site
Durham, North Carolina · Recruiting
Research Site
Wilson, North Carolina · Recruiting
Research Site
Canton, Ohio · Recruiting
Research Site
Maumee, Ohio · Recruiting
Research Site
Philadelphia, Pennsylvania · Recruiting
Research Site
Nashville, Tennessee · Recruiting
Research Site
Dallas, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.